I agree that this site is using cookies. You can find further informations here.
X
Khiali, Sajad
30  results:
Search for persons X
?
1

SGLT2 Inhibitors' Cardiovascular Benefits in Individuals Wi..:

Khiali, Sajad ; Taban‐Sadeghi, Mohammadreza ; Sarbakhsh, Parvin...
The Journal of Clinical Pharmacology.  63 (2023)  12 - p. 1307-1323 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Empagliflozin and colchicine in patients with reduced left ..:

Khiali, Sajad ; Taban-Sadeghi, Mohammadreza ; Sarbakhsh, Parvin...
Trials.  24 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
3

Empagliflozin and colchicine in patients with reduced left ..:

Khiali, Sajad ; Taban-Sadeghi, Mohammadreza ; Sarbakhsh, Parvin..
European Journal of Clinical Pharmacology.  80 (2023)  1 - p. 93-104 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Correction to: Empagliflozin and colchicine in patients wit..:

Khiali, Sajad ; Taban-Sadeghi, Mohammadreza ; Sarbakhsh, Parvin..
European Journal of Clinical Pharmacology.  80 (2023)  2 - p. 301-303 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Effect of Caffeine Consumption on Cardiovascular Disease: A..:

Khiali, Sajad ; Agabalazadeh, Amin ; Sahrai, Hadi...
Pharmaceutical Medicine.  37 (2023)  2 - p. 139-151 , 2023
Link: https://doi.org/10.1007/..
 
?
6

New Variants of SARS‐CoV‐2 and Next Generation of COVID‐19 ..:

Khiali, Sajad ; Entezari‐Maleki, Taher
The Journal of Clinical Pharmacology.  62 (2022)  9 - p. 1055-1058 , 2022
Link: https://doi.org/10.1002/..
 
?
7

Investigational antiviral drugs for the treatment of COVID-..:

Beheshtirouy, Samineh ; Khani, Elnaz ; Khiali, Sajad.
Archives of Virology.  167 (2022)  3 - p. 751-805 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Potential pharmacologic treatments for COVID-19 smell and t..:

Khani, Elnaz ; Khiali, Sajad ; Beheshtirouy, Samineh.
European Journal of Pharmacology.  912 (2021)  - p. 174582 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Therapeutic Application of Corticosteroids in COVID‐19: A F..:

Khiali, Sajad ; Entezari‐Maleki, Taher
The Journal of Clinical Pharmacology.  61 (2021)  9 - p. 1145-1148 , 2021
Link: https://doi.org/10.1002/..
 
?
10

Remdesivir for treatment of COVID-19; an updated systematic..:

Rezagholizadeh, Afra ; Khiali, Sajad ; Sarbakhsh, Parvin.
European Journal of Pharmacology.  897 (2021)  - p. 173926 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Potential COVID‐19 Therapeutic Agents and Vaccines: An Evid..:

Khani, Elnaz ; Khiali, Sajad ; Entezari‐Maleki, Taher
The Journal of Clinical Pharmacology.  61 (2021)  4 - p. 429-460 , 2021
Link: https://doi.org/10.1002/..
 
?
12

Pharmacist-Directed Self-Management of Blood Pressure Versu..:

Khiali, Sajad ; Khezerlo-aghdam, Naser ; Namdar, Hossein.
High Blood Pressure & Cardiovascular Prevention.  28 (2021)  3 - p. 283-290 , 2021
Link: https://doi.org/10.1007/..
 
?
13

A Comprehensive Review of Tocilizumab in COVID‐19 Acute Res..:

Khiali, Sajad ; Khani, Elnaz ; Entezari‐Maleki, Taher
The Journal of Clinical Pharmacology.  60 (2020)  9 - p. 1131-1146 , 2020
Link: https://doi.org/10.1002/..
 
?
14

Anticoagulation in COVID-19: DDI Perspective:

Khiali, Sajad ; Entezari-Maleki, Taher
Clinical and Applied Thrombosis/Hemostasis.  26 (2020)  - p. 107602962095945 , 2020
Link: https://doi.org/10.1177/..
 
?
15

Tocilizumab in COVID-19 management: addressing time of star..:

Khiali, Sajad ; Entezari-Maleki, Taher
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986926/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15